Activating immunity in the liver. II. IFN-β attenuates NK cell-dependent liver injury triggered by liver NKT cell activation

Journal of Immunology

Volumn 168, Issue 8, 2002, Pages 3763-3770

  Trobonjaca, Zlatko ^a   Kröger, Andrea ^a   Stober, Detlef ^a   Leithäuser, Frank ^a   Möller, Peter ^a   Hauser, Hansjörg ^a   Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; GALACTOSYLCERAMIDE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; IMMUNE RESPONSE; IMMUNITY; IMMUNOSTIMULATION; LIVER INJURY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0037090312     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.8.3763     Document Type: Article

References (42)

1. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFNγ release by liver NKT cells
2. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
3. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide
4. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
5. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide
6. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
7. + NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells
8. Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000) loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL- 15
9. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells
10. Costimulation-dependent modulation of experimental autoimmune encephalomy-elitis by ligand stimulation of Val4 NK T cells
11. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways
12. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12
13. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
14. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement
15. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice
16. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
17. Rapid death and regeneration of NKT cells in anti-CD3ε or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis
18. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
19. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
20. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
21. Noncytolytic control of viral infections by the innate and adaptive immune response
22. Interieukin-18 regulates both Th1 and Th2 responses
23. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development
24. IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells
25. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice
26. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice
27. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
28. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-γ
29. Mechanisms of class I restricted immunopathology: A transgenic mouse model of fulminant hepatitis
30. + T cells upon NK T or T cell activation
31. Human recombinant interferon-β influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors
32. Interferon-β induces the development of type 2 dendritic cells
33. A role for IFN-αβ in virus infection-induced sensitization to endotoxin
34. Viral infection causes rapid sensitization to lipopolysaccharide: Central role of IFN-αβ
35. IFN-β1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: Relevance to IFN-β1b therapeutic effects in multiple sclerosis
36. Role of interferon-α in promoting T helper cell type 1 responses in the small intestine in coeliac disease
37. Influenza A virus-induced IFN-αβ and IL-18 synergistically enhance IFN-γ gene expression in human T cells
38. IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells
39. Two roads diverged: Interferon αβ- and interleukin 12-mediated pathways in promoting T cell interferon-γ responses during viral infection
40. Interferon αβ-mediated inhibition and promotion of interferon γ: STATI resolves a paradox
41. IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters
42. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes